Matias Adan Preisegger

Title: The Innovative Contributions of Matias Adan Preisegger

Introduction

Matias Adan Preisegger, an accomplished inventor based in Buenos Aires, Argentina, has made significant strides in the field of biomedical research. With his noteworthy patent, he continues to contribute to advances in cancer treatment and hepatic fibrosis management.

Latest Patents

Matias holds a patent related to the TGF-receptor II isoform and a fusion peptide. His invention involves an isoform of the TGF beta receptor II that consists of approximately 80 amino acids and notably lacks a transmembrane domain. The isoform encompasses the amino acid sequence identified in SEQ ID No. 12. Moreover, this novel isoform may include the amino acid sequence set forth in SEQ ID No. 2 or sequences that exhibit at least 85% sequence identity to it. His patent also encompasses a fusion peptide integrating the isoform of the TGF beta II receptor, which is fused to a ligand. This innovation utilizes a vector containing the fusion peptide for potential treatment of cancer and/or hepatic fibrosis. Additionally, an antibody that binds the soluble isoform of the TGF beta II receptor is described, which binds to the sequence noted in SEQ ID No. 12 and can be applied in in vitro methods.

Career Highlights

Throughout his career, Matias has collaborated with prominent research institutions, including the National Scientific and Technical Research Council (Consejo Nacional de Investigacion Cientifica y Tecnica) and Fundacion Articula. His work at these institutions has provided a strong foundation for his innovative pursuits in biotechnology and medicine.

Collaborations

Matias has worked alongside several esteemed colleagues, including Ana Romo and Anabela Belen La Colla. Their collaborations have undoubtedly enriched his research endeavors, fostering an environment where groundbreaking ideas can flourish.

Conclusion

Matias Adan Preisegger's contributions to the scientific community through his patent on the TGF-receptor II isoform and fusion peptide highlight the importance of innovation in addressing major health challenges such as cancer and liver diseases. His career, characterized by productive collaborations and a commitment to research excellence, positions him as a valuable asset in the field of biotechnology.